The Asia Pacific epinephrine market is expected to reach US$ 953.08 Mn in 2027 from US$ 486.79 Mn in 2019. The market is estimated to grow at a CAGR of 8.9% from 2019-2027.
The growth of the market is driven by factors such as the increasing production of generic epinephrine, cheaper epinephrine products, and government regulations in the Asia Pacific region. Whereas, lack of availability of epinephrine drug is likely to harm the growth of the market in the coming years.
Anaphylaxis is a severe, life‑threatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of the human body. Anaphylaxis is caused mainly by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body.
The incidence of anaphylaxis is increasing, More than 1 billion people in the world suffered from respiratory diseases in 2018, asthma to which is a major contributor, according to the World Health Organization (WHO The top 3 countries for both asthma incidence and prevalence in Asia were India, China, and Indonesia, driven largely by population size nearly half (48%) of estimated and over half (56%) of asthma emergency room visits were estimated in Southeast Asia (includes India), and western Pacific regions (includes China). The global burden of disease data analysis revealed more than one million premature deaths attributable to the ambient air pollution in 2015 in India. More than one million additional deaths can be attributed to household air pollution. Various government initiatives to provide advanced healthcare facilities have also been introduced in the Asian countries, which helps in the treatment of life-threatening diseases such as anaphylaxis. Anaphylaxis requires immediate medical treatment, and it can turn lethal if not treated properly. Allergies put an economic burden on healthcare systems in many countries. Therefore, the demand for epinephrine is expected to increase during the forecast period.
The increasing production of generic epinephrine, in the Asia Pacific, is expected to drive epinephrine market growth as people in Asia Pacific people are more prone to allergy and infections. As in other Asia Pacific countries, China faces a continuous and significant increase in the number of anaphylaxis cases. This rising number of anaphylaxis cases and the growing pharmaceutical industry in the country create a lucrative opportunity and the presence of an established market for epinephrine.
ASIA PACIFIC EPINEPHRINE– MARKET SEGMENTATION
Asia Pacific Epinephrine Market - By Product Type
Asia Pacific Epinephrine Market - By Application
Asia Pacific Epinephrine Market - By Distribution Channel
Asia Pacific Epinephrine Market - By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 486.79 Million |
| Market Size by 2027 | US$ 953.08 Million |
| CAGR (2019 - 2027) | 8.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Epinephrine Market is valued at US$ 486.79 Million in 2019, it is projected to reach US$ 953.08 Million by 2027.
As per our report Asia Pacific Epinephrine Market, the market size is valued at US$ 486.79 Million in 2019, projecting it to reach US$ 953.08 Million by 2027. This translates to a CAGR of approximately 8.9% during the forecast period.
The Asia Pacific Epinephrine Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Epinephrine Market report:
The Asia Pacific Epinephrine Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Epinephrine Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Epinephrine Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Epinephrine Market
